Breaking News · News
Microsoft and Boehringer Ingelheim to Study Patient Digital Twins for Clinical Trials
On October 22, Microsoft and Boehringer Ingelheim announced a joint study of patient digital twins. The first phase will focus on lung health as the companies assess the scientific and technical feasibility of the approach, including clinical trial simulation.
0
↗
